sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology plc
The Vanguard Group, Inc. has released Form 8.3, revealing its position in Mural Oncology plc as of May 1, 2025. The disclosure is in accordance with Rule 8.3 of the Irish Takeover Panel Act of 1997, detailing holdings in Mural Oncology's securities. Vanguard holds 772,705 ordinary shares, representing a 4.47% stake in the company.
Additionally, it has made a recent purchase of 18 ordinary shares at USD 2.61 per unit. Currently, Vanguard has not participated in any derivative transactions or entered into indemnity agreements related to Mural Oncology's securities. The disclosure clarifies that no supplemental Form 8 is attached, and no other parties are implicated in the offer.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.